Literature DB >> 202823

Recurrent mixed tumors of the parotid gland--results of surgical therapy.

W E Fee, D R Goffinet, T C Calcaterra.   

Abstract

Entities:  

Mesh:

Year:  1978        PMID: 202823     DOI: 10.1288/00005537-197802000-00008

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


× No keyword cloud information.
  5 in total

1.  Recurrent pleomorphic adenoma: uninodular versus multinodular disease.

Authors:  H Rowley; M Murphy; D Smyth; T P O'Dwyer
Journal:  Ir J Med Sci       Date:  2000 Jul-Sep       Impact factor: 1.568

2.  The rate of facial nerve dysfunction and time to recovery after intraparotid and extraparotid facial nerve exposure and protection in head and neck cutaneous tumor surgery.

Authors:  Yasuhiro Nakamura; Yukiko Teramoto; Yuri Asami; Taichi Imamura; Sayuri Sato; Ryota Tanaka; Hiroshi Maruyama; Yoshiyuki Nakamura; Yasuhiro Fujisawa; Manabu Fujimoto; Akifumi Yamamoto
Journal:  Int J Clin Oncol       Date:  2017-06-09       Impact factor: 3.402

3.  Pleomorphic adenoma of the parotid gland: a 13-year experience of consequent management by lateral or total parotidectomy.

Authors:  Orlando Guntinas-Lichius; Carsten Kick; J Peter Klussmann; Markus Jungehuelsing; Eberhard Stennert
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-07-22       Impact factor: 2.503

4.  The surgical management of recurrent or residual pleomorphic adenomas of the parotid gland. Analysis and results in 40 patients.

Authors:  H Leverstein; R M Tiwari; G B Snow; J E van der Wal; I van der Waal
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 3.236

5.  Clinical manifestations of recurrent parotid pleomorphic adenoma.

Authors:  Myung-Whan Suh; J Hun Hah; Seong Keun Kwon; Young-Ho Jung; Tack-Kyun Kwon; Kwang Hyun Kim; Myung-Whun Sung
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-12-31       Impact factor: 3.372

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.